• Save
Ophaco Belgium
Upcoming SlideShare
Loading in...5
×
 

Ophaco Belgium

on

  • 2,023 views

 

Statistics

Views

Total Views
2,023
Views on SlideShare
1,994
Embed Views
29

Actions

Likes
1
Downloads
0
Comments
0

5 Embeds 29

http://www.coopseurope.coop 20
http://ns39179.ovh.net 4
http://www.slideshare.net 3
http://coopseurope.coop 1
http://health.medicbd.com 1

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Ophaco Belgium Ophaco Belgium Presentation Transcript

  • Klik om het opmaakprofiel te bewerken EUROPEAN SEMINAR • Klik om de opmaakprofielen van de modeltekst te bewerken CO-OPERATIVE ENTERPRISES IN • Tweede niveau THE PHARMACY SECTOR: • OPPORTUNITIES & CHALLENGES Derde niveau • Vierde niveau • ROMA, MARCH 30th – 31st, 2009 Vijfde niveau Route de Lennik 900 B-1070 Bruxelles T : +32.25 299 242 F : +32.25 299 376 02/04/2009 1
  • BRIEF DESCRIPTION OF is constituted by 15 consumer co-operatives companies, specifically active in the intermediary distribution (8 wholesalers, 600 pharmacies, 50 Health Products shops) of medicines (human and animal) and health products (medical devices, medical nutrition or cosmetics). 02/04/2009 2
  • OPHACO is one of the major founding and contributing member of the European Union of the Social Pharmacies (EUSP) represented also in France, Italy, Poland, Portugal, The Netherlands and Switzerland. 02/04/2009 3
  • COUNTRY LEGISLATIVE FRAMEWORK Wholesalers, pharmacies, pharmacists are submitted to the European regulations, transposed in the Belgian Law: • Dir. 1985/433/EEC : mutual recognition of diplomas, certificates, facilitatation of the effective exercise of the right of establishment in the field of Pharmacy; • Dir. 1985/432/EEC : Activities in the field of pharmacy; • Dir. 2001/83/EC : Community code medicinal products. 02/04/2009 4
  • Belgian regulations concerning : • health practitioners and the pharmacist: Art. 4 royal decree n° 78, royal decree 2009 01 21; • pharmacies: royal decree 1974 09 25; • medicines: law 2006 05 01; royal decree 2006 12 14. Other BE regulations : Reimbursement of health care to the patients (including medicines and health products (law 1994 07 14 and application regulations); Transparency and the governance of companies, enterprises and societies, co-operative or not. 02/04/2009 5
  • DESCRIPTION OF THE SECTOR (FACTS & FIGURES) Medicine distribution and dispensation are the vital link between the producers and the patients/consumers. The actors of the medicines sector in Belgium are the producers (400 medicines or medical devices companies or representing producers companies), wholesalers (16 companies), Pharmacies (5.200). 02/04/2009 6
  • 80% of the medicines consumption depends from abroad. The compulsory Social protection covers 50% of the health products market for which the average patient level of co-payment is about 20% of the costs. 02/04/2009 7
  • ROLE OF THE CO-OPERATIVES IN THE SECTOR Each consumer co-operatives member of OPHACO deals with the medicines distribution and dispensation. The market share covered by the members of OPHACO is about 20%. This success is due to the fact that OPHACO members represent an alternative to the monopoly of the stand alone pharmacist’s pharmacy. Those alternatives are based on the specific Values and Finalities of the Co-operative entrepreneurship and of the Social Pharmacies: Quality, efficacity, safety, accessibility. 02/04/2009 8
  • STRENGTHS AND WEAKNESSES OF THE CO-OPERATIVE MOVEMENT IN THE PHARMACY SECTOR The turnover of the medicines distribution and dispensation depends for 50% from the reimbursable medicines. The income of the distribution and the dispensation represents respectively 5% and 15 % of the global turnover VAT excluded. As a consequence, the dispositions aimed to reduce the public expenditure have a direct impact on the economy of the sector. 02/04/2009 9
  • A strong point of the co-operatives is constituted by their coordinated organization model which permits scale economies and a global coherence of their network. As a result, the average turnover of a co-operative pharmacy is two time higher than the average one of the stand alone pharmacy. This indicates the global satisfaction of their 2.2 million co-operators. 02/04/2009 10
  • The competence of the pharmacies teams through their in company continued training constitutes a major strong point strengthening the co-operative pharmacy. A weakness is actually constituted by the difficulties to recruit pharmacists, a global problem of the sector. 02/04/2009 11
  • THE MAJOR CO-OPERATIVE ENTERPRISES OF THE COUNTRY IN THE PHARMACY SECTOR SCRL MULTIPHARMA CVBA, PHARMACIES POPULAIRES LIEGEOISES SCRL CV VOORUIT CV DE VOORZORG HASSELT CV DE VOORZORG MECHELEN PHARMACIES POPULAIRES “ LA SAUVEGARDE ” SC LES PHARMACIES DU PEUPLE SCRL V-PHARMA SCRL EPC CVBA VIVANTIA VZW M.S.I. ROESELARE-TIELT VZW APOTHEKEN DE VOLKSMACHT IEPER CV APOTHEEK IN HET ZWAARD DELINDEBOOM APOTHEEK CV DE VOLKSMACHT TURNHOUT. 02/04/2009 12
  • FUTURE PRIORITIES AND STRATEGIES The priorities of the Belgian co-operative Pharmacies and Wholesalers for the next months are: •The new system of payment of the pharmacist and the wholesaler; •The traceability of the medicines from the producer to the patient; •The new Information and Communication technologies: electronic prescription, memories and data transmission; 02/04/2009 13
  • The strategies remain in the expansion of the networks to reinforce the competitive advantage of the companies. 02/04/2009 14